NCCN Guidelines Insights: Bladder Cancer, Version 2.2016

Restricted access

These NCCN Guidelines Insights discuss the major recent updates to the NCCN Guidelines for Bladder Cancer based on the review of the evidence in conjunction with the expert opinion of the panel. Recent updates include (1) refining the recommendation of intravesical bacillus Calmette-Guérin, (2) strengthening the recommendations for perioperative systemic chemotherapy, and (3) incorporating immunotherapy into second-line therapy for locally advanced or metastatic disease. These NCCN Guidelines Insights further discuss factors that affect integration of these recommendations into clinical practice.

Provided content development and/or authorship assistance.

Supplementary Materials

    • Supplemental Material (PDF 219 KB)
All Time Past Year Past 30 Days
Abstract Views 0 0 0
Full Text Views 501 501 27
PDF Downloads 55 55 4
EPUB Downloads 0 0 0